Document is current

Any future updates will be listed below

A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system

Crossref DOI link: https://doi.org/10.1038/s41598-025-24217-y

Published Online: 2025-11-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark